Background: Stroke reduction with direct oral anticoagulants (DOACs) in atrial fibrillation
(AF) is dependent on adherence and persistence in the real-world setting. Individual study …

Introduction Medications cannot exert their effect if not taken as prescribed by patients. Our
objective was to summarise the observational evidence on adherence to oral anticoagulants …

It is well established that direct oral anticoagulants (DOACs) are the cornerstone of
anticoagulant strategy in atrial fibrillation (AF) and venous thromboembolism (VTE) and …

Background Poor adherence to oral anticoagulation in elderly patients with atrial fibrillation
(AF) has been shown to negatively impact health care costs, morbidity, and mortality …

Atrial fibrillation (AF) is associated with an increased risk of stroke, which can be prevented
by the use of oral anticoagulation. Although non-vitamin K antagonist oral anticoagulants …

Background Direct-acting oral anticoagulants (DOACs) were developed as an alternative to
warfarin to treat and prevent thromboembolism, including stroke prevention in non-valvular …

Background In recent years, mobile medical technology has made great progress in chronic
disease management, but its application in patients with atrial fibrillation (AF) still needs to …

Background Poor medication adherence puts patients who require antithrombotic therapy at
greater risk of complications. We started a multidisciplinary Adult Outpatient Thrombosis …

Background A high degree of adherence to direct oral anticoagulants is essential for
reducing the risk of ischaemic stroke and systemic embolism in patients with atrial fibrillation …

Background Direct oral anticoagulants are available for patients with atrial fibrillation.
Objective This study compared adherence and persistence of once-daily (QD) vs twice-daily …